NOVAMET
Home/Scientific Directory/GLOW Peptide Protocol
Cellular Health100MG
GLOW Peptide Protocol
scienceScientific ProtocolverifiedVetted Formulation
biotechGHK-Cu Copper Binding & Extracellular Matrix Remodeling

GLOW Peptide Protocol

Copper peptide complex (GHK-Cu) researched for dermal extracellular matrix remodeling, collagen synthesis, and youthful cellular regeneration.

Transparent Pricing₦125,000 / protocol

infoResearch & Clinical Context

Advanced cosmetic cellular protocol targeting skin density, elasticity, and anti-aging.

Mechanism & Biological Overview

GLOW is powered by GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex), a naturally occurring tripeptide with exceptional biological affinity for skin matrix repair. It stimulates Collagen I & III synthesis, activates glycosaminoglycans, and remodels damaged dermal tissue.

Key Biological Highlights & Benefits

  • checkStimulates dermal Collagen I, Collagen III, and Elastin production
  • checkPromotes extracellular matrix repair for firm, youthful skin structure
  • checkAccelerates tissue recovery and reduces dermal inflammation
  • checkEnhances microvascular skin nourishment for a healthy radiant glow
menu_book

Scientific Literature Abstract

"GHK-Cu modulates the expression of over 4,000 human genes. It upregulates genes responsible for collagen and elastin synthesis while downregulating metalloproteinases (MMPs) that break down matrix proteins, restoring youthfulness to skin architecture."

hubTarget Receptor Pathways

GHK-Cu Copper Peptide Receptor Interactions
Pro-Collagen Type I & III mRNA Transcription
TGF-Beta (Transforming Growth Factor) Signaling
Dermal Glycosaminoglycan (GAG) Synthesis

Frequently Asked Questions

What makes GHK-Cu (GLOW) unique for skin repair?

GHK-Cu delivers bioavailable copper directly to dermal fibroblast cells, activating natural gene expression for collagen synthesis and tissue remodeling.

Explore Related Scientific Interventions

Metabolic Health₦145,000 / month

Semaglutide Protocol

A GLP-1 receptor agonist studied for appetite modulation and glycemic signaling pathways in metabolic health.

View Full Details arrow_forward
Weight Management₦210,000 / month

Tirzepatide Dual Agonist

Dual GIP and GLP-1 receptor agonist targeting complementary metabolic pathways for body composition and appetite research.

View Full Details arrow_forward
Weight Management₦280,000 / month

Retatrutide Triple Agonist

Triple receptor agonist (GIP, GLP-1, and Glucagon) studied for its potential effects on metabolic rate and lipid mobilization pathways.

View Full Details arrow_forward
gavel

Clinical & Legal Disclaimer

Medical Disclaimer: Information provided on this website is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Product availability, indications, regulatory status, and suitability may vary. Any medical treatment should be considered with an appropriately qualified healthcare professional.

NOVAMET does not guarantee specific weight-loss, metabolic, or treatment outcomes.